Peter Vanlandschoot

A universal influenza A vaccine based on the extracellular domain of the M2 protein

Sabine Neirynck, Tom Deroo, Xavier Saelens et al. · Nature Medicine · 1999 · 751 citations

Vaccination, Cross-protection, Vaccine Development +11

CXCR4 nanobodies (VHH-based single variable domains) potently inhibit chemotaxis and HIV-1 replication and mobilize stem cells

Sven Jähnichen, Christophe Blanchetot, David Maussang et al. · Proceedings of the National Academy of Sciences · 2010 · 244 citations · Full text

Cell Therapy, Engineering, Immunology +21

Llama-Derived Single Domain Antibodies to Build Multivalent, Superpotent and Broadened Neutralizing Anti-Viral Molecules

Anna Hultberg, Nigel Temperton, Valérie Rosseels et al. · PLoS ONE · 2011 · 185 citations · Full text

Llama-derived Single Variable Domains (Nanobodies) Directed against Chemokine Receptor CXCR7 Reduce Head and Neck Cancer Cell Growth in Vivo

David Maussang, Azra Mujić-Delić, Francis J. Descamps et al. · Journal of Biological Chemistry · 2013 · 140 citations · Full text

Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection

Lorena Itatí Ibañez, Marina De Filette, Anna Hultberg et al. · The Journal of Infectious Diseases · 2011 · 114 citations · Full text

Nanoparticles, Nanomedicine, Cross-protection +12